Streetbeat News

Stock Prices

IDEX

Ideanomics Inc (NASDAQ:IDEX) shares are trading lower by 9.1% to $2.44, despite no company-specific news. The stock is falling amid weakness in EV- and EV-related companies after Tesla Inc reported worse-than-expected Q3 financial results. This can erode investor confidence in the broader EV sector, causing them to reevaluate their investments in EV-related companies, including Ideanomics.

Portfolio Pulse from Henry Khederian

October 19, 2023 | 6:24 pm

MS

Morgan Stanley reported Q3 earnings with a net profit of $2.4 billion, beating analysts' expectations. However, shares fell 1.5% following the announcement. Analysts from Oppenheimer, BMO Capital, and Evercore ISI Group have lowered their price targets on Morgan Stanley.

Portfolio Pulse from Lisa Levin

October 19, 2023 | 6:22 pm

PG

Procter & Gamble Co (NYSE:PG) reported better-than-expected Q3 earnings, with sales growth of 6.1% YoY to $21.87 billion and adjusted EPS of $1.83. Despite this, shares fell 0.4% to trade at $148.48. Analysts from Stifel and Wells Fargo have increased their price targets on Procter & Gamble following the earnings announcement.

Portfolio Pulse from Lisa Levin

October 19, 2023 | 6:18 pm

WKHS

Workhorse Group Inc's (NASDAQ:WKHS) shares are down 8.4% to $0.42, with no company-specific news driving the decline. The stock is dropping amid a broader decline in the EV industry, following Tesla Inc's disappointing Q3 financial results. Tesla's performance often impacts the entire EV sector, leading to a general loss of confidence in EV-related stocks, including Workhorse.

Portfolio Pulse from Henry Khederian

October 19, 2023 | 6:17 pm

TMO

A significant amount of unusual options activity has been observed for Thermo Fisher Scientific (NYSE:TMO), with a split sentiment of 58% bullish and 41% bearish among big-money traders. The options trades have targeted a price range from $370.0 to $570.0 for TMO over the last 3 months. The company's stock price is currently up 1.23% at $473.0. Several financial institutions have given their ratings and price targets for TMO, with JP Morgan maintaining an Overweight rating and a price target of $630.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 6:17 pm

DUOL

GOOG

Google is launching a new feature on Google Search to help users practice and improve their English skills. The feature, which will be rolled out on Android devices in several countries, provides interactive speaking practice for language learners translating to or from English. The tool uses AI and machine learning to provide personalized feedback and recommendations for improvement. The news coincides with a slight drop in Duolingo's stock.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 6:15 pm

TSLA

Tesla Inc's stock plunged more than 8% following its Q3 earnings miss. Several analysts lowered their price targets for the company, citing low demand for the new Model 3 and the Cybertruck. Despite the bearish reaction, technical analysis suggests that the stock may see higher prices over the next few days due to its relative strength index (RSI) dropping to about 30%, indicating it is oversold.

Portfolio Pulse from Melanie Schaffer

October 19, 2023 | 6:08 pm

NVO

A significant investor has taken a bearish stance on Novo Nordisk (NYSE:NVO), with 84% of the detected trades being bearish. The trades include 5 puts amounting to $201,731 and 8 calls amounting to $837,742. The targeted price range for Novo Nordisk over the last 3 months is from $57.5 to $145.0. The current price of NVO is down by 2.78% at $97.77. Argus Research has downgraded its action to Buy with a price target of $110.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 6:01 pm

JNJ

A significant investor has taken a bearish stance on Johnson & Johnson (NYSE:JNJ), with 61% of recent trades being bearish and 38% bullish. The total amount for put options is $496,236 and for call options is $354,520. Whales have been targeting a price range from $140.0 to $185.0 for JNJ over the last 3 months. The current price of JNJ is $152.7. RBC Capital, Barclays, and Cantor Fitzgerald have given price targets of $178, $162, and $215 respectively.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 6:01 pm

RCEL

Analysts have provided bullish ratings for AVITA Medical (NASDAQ:RCEL) in the last quarter, with an average price target of $25.6, a high of $27.00, and a low of $23.00. This average price target has increased by 40.27% over the past month.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 6:00 pm